Global Burden of Disease: Determining Priorities on a Global Scale

Sunday, February 19, 2017: 3:00 PM-4:30 PM
Room 309 (Hynes Convention Center)
Abraham Flaxman, Institute for Health Metrics and Evaluation, Seattle, WA
The Global Burden of Disease is the most comprehensive effort to measure epidemiological levels and trends worldwide using big data, disease models, and a network of disease and country experts. In the GBD, we estimate disease prevalence and quantify the relative harm caused by 300 diseases and injuries. Disability-adjusted life years allow comparison of diseases and different health outcomes. GBD data are used to set global priorities and to understand how health challenges are shifting over time.